Content
and Copyright
i
Pediatric Anthrax Clinical Management
-
Published Date:
May 2014
Source:Pediatrics. 2014; 133(5):e1411-e1436Language:English
[PDF-585.17 KB]
Details:
-
Alternative Title:Pediatrics
-
Personal Author:
-
Description:Anthrax is a zoonotic disease caused by Bacillus anthracis, which has multiple routes of infection in humans, manifesting in different initial presentations of disease. Because B anthracis has the potential to be used as a biological weapon and can rapidly progress to systemic anthrax with high mortality in those who are exposed and untreated, clinical guidance that can be quickly implemented must be in place before any intentional release of the agent. This document provides clinical guidance for the prophylaxis and treatment of neonates, infants, children, adolescents, and young adults up to the age of 21 (referred to as "children") in the event of a deliberate B anthracis release and offers guidance in areas where the unique characteristics of children dictate a different clinical recommendation from adults.
-
Subject:
-
Pubmed ID:24777226
-
Pubmed Central ID:PMC4479255
-
Document Type:
-
Name as Subject:
-
Place as Subject:
-
Collection(s):
-
Main Document Checksum:
- File Type:
-
Supporting Files:
text/xml
No Related Documents.
You May Also Like:
-
Published Date:Source:Description:File Type:[PDF - 3.32 MB]
File Type:[PDF - 3.32 MB]
Published Date:Source:File Type:[PDF - 40.09 KB]
File Type:[PDF - 40.09 KB]
Published Date:Source:Description:File Type:[PDF - 418.91 KB]
File Type:[PDF - 418.91 KB]
Published Date:Source:Description:File Type:[PDF - 2.74 MB]
File Type:[PDF - 2.74 MB]
Published Date:Source:Description:File Type:[PDF - 824.87 KB]
File Type:[PDF - 824.87 KB]
Have Questions?
Visit CDC Info
Email
CDC-INFO
Open 24/7
CDC INFORMATION
CONNECT WITH CDC
